PRMT1 and Miyoshi myopathy: In conclusion, our data demonstrated that PRMT1 enhanced MM cell proliferation and OCR levels and decreased cell apoptosis and ROS levels by binding with WTAP to regulate NDUFS6 expression via an m6A-dependent manner.